Tubotympanic CSOM (Safe Type)
Definition: A chronic infection of the middle ear cleft localized to the mucosa, mostly in the anteroinferior part. It is a mucosal disease with no evidence of squamous epithelium invasion.
Aetiology
Starts in childhood; common in that age group.
- Sequela of Acute Otitis Media: Usually following exanthematous fever, leaving a large central perforation.
- Ascending Infections: Via Eustachian tube from infected tonsils, adenoids, or sinuses.
- Allergy: Persistent mucoid otorrhoea due to ingestants (milk, eggs, fish).
Pathology
Characterized by co-existing healing (fibrosis) and destruction.
- Perforation: ALWAYS CENTRAL. Variable size/position in Pars Tensa.
- Mucosa: Normal (quiescent) or Oedematous/Velvety (active).
- Polyp: Smooth, pale mass of oedematous mucosa. (Contrast: Pink, fleshy polyp in atticoantral disease).
- Ossicular Chain: Usually intact/mobile. Necrosis may occur (Long process of incus).
- Tympanosclerosis: Hyalinization/calcification (chalky white deposits). May cause fixation and conductive deafness.
- Fibrosis/Adhesions: May impair ossicular mobility or block ET.
Bacteriology
Culture: Usually multiple organisms.
- Aerobes: Pseudomonas aeruginosa, Proteus, E. coli, Staph. aureus.
- Anaerobes: Bacteroides fragilis, Anaerobic Streptococci.
Classification of Disease
1. Tubotympanic (Mucosal)
| State | Features |
|---|---|
| Active | Perforation + Inflammation + Mucopurulent discharge. |
| Inactive | Permanent perforation + No inflammation + Dry ear. |
| Healed | TM healed (often 2 layers, atrophic/retracted) + Tympanosclerosis. |
2. Atticoantral (Squamosal)
(Provided for contrast)
- Inactive: Retraction pockets (Pars flaccida/Posterosuperior tensa).
- Active: Cholesteatoma present. Bone erosion + Granulation + Offensive discharge.
Clinical Features
- Ear Discharge: Non-offensive, mucoid/mucopurulent. Constant or intermittent (triggered by URI or water entry).
- Hearing Loss: Conductive, rarely > 50 dB. Paradoxical Effect: Patient hears better when ear is wet. Mechanism: Discharge produces "Round Window Shielding", maintaining phase differential. In dry ear with perforation, sound cancels out at oval/round windows.
- Perforation: Central (Anterior/Posterior/Inferior to malleus handle) or Subtotal.
- Mucosa: Red/swollen if inflamed; Pale pink/moist if normal.
Assessment
- Microscope Examination: Essential. Checks for granulations, epithelial ingrowth, ossicular status, and hidden cholesteatoma.
- Audiogram: Assess degree/type of loss (usually Conductive).
- Culture & Sensitivity: For antibiotic selection.
- Imaging (X-ray/CT): Sclerotic mastoid or clouding. No bone destruction (unlike atticoantral).
Treatment
Aim: Control infection → Eliminate discharge → Restore hearing.
1. Medical Management
A. Aural Toilet:
- Remove discharge/debris (Suction, Dry mopping, or Irrigation).
- Note: Ear must be dried after irrigation.
B. Ear Drops (Mainstay of Treatment):
- Contents: Antibiotics (Neomycin, Polymyxin, Chloromycetin, Gentamicin) + Steroids (for local anti-inflammatory effect).
- Method of Use:
- Patient lies down with diseased ear up.
- Antibiotic drops are instilled.
- Intermittent pressure applied on Tragus. (Essential for solution to reach middle ear).
- Frequency: 3–4 times a day.
- Acid pH: Irrigations with 1.5% Acetic Acid are useful to eliminate Pseudomonas.
⚠ Care & Complications:
- May cause maceration of canal skin, local allergy, or fungal growth.
- Risk of organism resistance.
- Ototoxicity: Some drops are potentially ototoxic (e.g., aminoglycosides).
C. Systemic Antibiotics: Useful only in acute exacerbations.
D. Precautions: Keep water out (bathing/swimming) and avoid hard nose blowing.
E. Treat Contributory Causes: Adenoids, Tonsils, Sinuses, Allergy.
2. Surgical Management
- Aural Polypectomy: ⚠ WARNING: Never avulse a polyp! It may arise from Stapes, Facial Nerve, or Horizontal Canal. Avulsion → Facial Paralysis or Labyrinthitis.
- Reconstructive Surgery: Myringoplasty (with/without ossicular reconstruction) once ear is dry (quiescent).
📚 Source: Dhingra ENT | Chapter 11
💬 Comments
No comments:
Post a Comment